Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

214
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
214
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

106
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
106
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

211
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
211
Oral Drug Delivery Systems: Delayed-Release Systems01:11

Oral Drug Delivery Systems: Delayed-Release Systems

126
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
126

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging Nanoformulation-Based Carrier Systems: New Insights into Promising Vaccine Delivery.

Current drug metabolism·2026
Same author

Intranasal Drug Delivery: Exploiting Nasal Anatomy for Enhanced Therapeutic Outcomes.

Current pharmaceutical design·2025
Same author

Role of Artificial Intelligence in Nanomedicine and Organ-specific Therapy: An Updated Review.

Current drug targets·2025
Same author

Artificial Intelligence in Medicine and Imaging Applications.

Current pharmaceutical design·2025
Same author

Ecological weed management and square planting influenced the weed management, and crop productivity in direct-seeded rice.

Scientific reports·2024
Same author

Emerging ROS-Modulating Technologies for Augmentation of the Wound Healing Process.

ACS omega·2022

Related Experiment Video

Updated: Mar 23, 2026

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel FilmWound Healing
04:09

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel FilmWound Healing

Published on: December 13, 2024

1.5K

Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization.

Kuldeep Rajpoot1,2

  • 1a Pharmaceutical Research Project Laboratory, Department of Pharmaceutical Sciences , Dr. Hari Singh Gour Vishwavidyalaya , Sagar , Madhya Pradesh , India.

Artificial Cells, Nanomedicine, and Biotechnology
|March 29, 2016
PubMed
Summary

This study developed a novel nanoemulsion-based organogel (NEOG) for topical acyclovir delivery to treat herpes simplex virus infections, showing promising sustained and site-specific drug release.

Keywords:
Acyclovirherpes simplex virusisopropyl myristatenanoemulsionorganogelrheologysorbitan monostearatetopical

More Related Videos

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

2.0K
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
09:30

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications

Published on: October 7, 2016

12.0K

Related Experiment Videos

Last Updated: Mar 23, 2026

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel FilmWound Healing
04:09

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel FilmWound Healing

Published on: December 13, 2024

1.5K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

2.0K
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
09:30

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications

Published on: October 7, 2016

12.0K

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Dermatology

Background:

  • Herpes simplex virus (HSV) infections require effective topical treatments.
  • Nanoemulsion-based organogels (NEOGs) offer potential for enhanced topical drug delivery.
  • Acyclovir is a common antiviral medication for HSV.

Purpose of the Study:

  • To develop and characterize a NEOG system loaded with acyclovir for topical HSV treatment.
  • To evaluate the gelling properties and drug release characteristics of the NEOG system.

Main Methods:

  • Formulation of NEOG using pseudo-ternary phase diagrams.
  • Rheological characterization (storage modulus G', loss modulus G″).
  • Determination of gel-sol transition temperature (Tg) and fractal dimension (Df).

Main Results:

  • The NEOG system demonstrated an increased non-birefringent, optically isotropic region with varying Smix (Kw) ratios.
  • NEOG C exhibited favorable rheological properties and compact network structures.
  • Increased density of the tubular network was observed with Kw, indicated by Tg and Df.

Conclusions:

  • The developed NEOG system possesses high gelling ability for sustained and site-specific acyclovir delivery.
  • This NEOG formulation shows potential for effective topical treatment of herpes simplex virus infections.